What Has Been The Evolution of the Large And Small-Scale Bioprocessing Market in Recent Years?
The large and small-scale bioprocessing market has seen considerable growth due to a variety of factors.
• The large and small-scale bioprocessing market has grown rapidly in recent years, expected to rise from $59.63 billion in 2024 to $67.85 billion in 2025, growing at a CAGR of 13.8%.
This growth is due to the growth of the medical industry, regulatory standards, technological advancements, the expansion of the pharmaceutical and biotechnology sectors, and rising concerns over food safety.
What Are the Future Growth Projections for the Large And Small-Scale Bioprocessing Market?
The large and small-scale bioprocessing market is expected to maintain its strong growth trajectory in upcoming years.
• The large and small-scale bioprocessing market is forecasted to grow rapidly, reaching $112.2 billion by 2029, with a CAGR of 13.4%.
The growth is attributed to higher healthcare spending, advancements in pharmaceutical and biotechnology sectors, and technological innovations. Major trends include the adoption of sustainable practices, hybrid sterilization techniques, and geographical expansion.
What Are The Core Factors Supporting Growth In The Large And Small-Scale Bioprocessing Market?
The growing demand for biologics is set to stimulate the large and small-scale bioprocessing market. Biologics, including vaccines and gene therapies, are essential in modern medicine, and both large-scale and small-scale bioprocessing play pivotal roles in their development. In February 2024, the FDA approved 55 new drugs in 2023, including 25 new biologic entities, reflecting an increased focus on biologics.
What Are The Major Segments Within The Global Large And Small-Scale Bioprocessing Market?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
Pre-Book The Large And Small-Scale Bioprocessing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Large And Small-Scale Bioprocessing Market?
Prominent businesses involved in both the large and small-scale bioprocessing marketplace are focusing on creating cutting-edge products like single-use centrifuge systems to better accommodate customer needs. These systems, which are pre-sterilized and disposable, are engineered for the separation of biological constituents used in bioprocessing. For example, Thermo Fisher Scientific Inc., an American biotech firm, in September 2022 unfurled its new product, DynaSpin Single-Use Centrifuge system. This system is aimed at upgrading large-scale cell culture harvesting processes by refining the separation stages, minimizing the quantity of depth filtration cartridges required, and offering advantages such as increased product yield, improved operational efficiency, reduced costs and sustainable production in biologics. The DynaSpin system supports sustainability objectives and curtails production costs by substantially reducing material use and waste generation in comparison to traditional harvesting systems.
Who Are the Key Players In The Large And Small-Scale Bioprocessing Market?
Major companies operating in the large and small-scale bioprocessing market are:
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• Bayer AG
• Sanofi S.A.
• Bristol Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline PLC
• 3M Company
• Takeda Pharmaceutical Company Ltd.
• Danaher Corporation
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Becton Dickinson and Company (BD)
• Teva Pharmaceutical Industries Ltd.
• Daiichi Sankyo Company
• Lonza Group
• Sun Pharmaceutical Industries Ltd.
• GE Healthcare Life Sciences
• Sartorius AG
• Dr. Reddy's Laboratories Ltd.
• Alkem Laboratories Limited
• Piramal Enterprises Ltd
What Is The Most Dominant Region In The Large And Small-Scale Bioprocessing Market?
North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
